Author: Adnkronos (Adnkronos )

(Adnkronos) – BERLIN, June 2, 2023 /PRNewswire/ — Protelion, a world-class provider of innovative cyber security solutions announced it has signed an exclusive distribution agreement with Omicron Group. The partnership will help Italian customers respond to the complex cyber challenges of increased digitalization with groundbreaking cyber solutions.   Rapid digitalization has dramatically changed the traditional information security...

(Adnkronos) – BEIJING, June 2, 2023 /PRNewswire/ — The city of Sanmenxia in central China’sHenan Province has inked 78 projects with a total investment of 92.76 billion yuan (about 13.07 billion U.S. dollars) during the 28th Sanmenxia Yellow River Cultural Tourism Festival.  The festival, along with the 9th China Characteristic Commodity Expo Fair, kicked off on...

(Adnkronos) – ISTANBUL, June 2, 2023 /PRNewswire/ — Arçelik, one of Europe’s leading home appliances companies, announces a significant milestone in its ongoing commitment to sustainability. Through its innovative initiatives, in 2022 alone, the company utilized a total of 13,207 tons of recycled plastic in the production of its appliances.  The company has successfully recycled...

(Adnkronos) – MIKOŁÓW, Poland, June 2, 2023 /PRNewswire/ — Renowned artist Mariusz Waras, known as M-CITY, has set an unprecedented benchmark by unveiling his globally acclaimed art collection, “DICTADOR M-CITY GOLDEN CITIES,” estimated to be worth an astounding one billion dollars. The vibrant city-state of Singapore, famous for its thriving art scene and cosmopolitan allure,...

(Adnkronos) – SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ — Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics’ NGS platforms. The territory is worldwide, and the field is oncology and cancer research.  Under the terms of the deal, Invivoscribe...

(Adnkronos) – An oral presentation titled “Phase 1/2 Study of DF1001, an Immune Modulating TriNKET® Targeting HER2, in Patients with Advanced Solid Tumors: Phase 1 DF1001 Monotherapy Dose Escalation Results” will be provided by Howard Safran, MD during the ASCO Developmental Therapeutics – Immunotherapy Session on June 4th.  WALTHAM, Mass., June 2, 2023 /PRNewswire/ —...

(Adnkronos) – SHANGHAI, June 2, 2023 /PRNewswire/ — Queclink Wireless Solutions, the world’s leading IoT device and solution provider, announced today that their GL530MG has received a 2023 IoT Evolution Asset Tracking Award from  IoT Evolution magazine, the leading publication covering the Internet of Things movement.  The GL530MG is a flexible asset tracker designed for...